UPM Institutional Repository

Development of nanoemulsion for efficient brain parental delivery of cefuroxime: designs,characterizations,and pharmacokinetics


Citation

Harun, Siti Norhawani and Amin Nordin, Syafinaz and Abd Gani, Siti Salwa and Shamsuddin, Ahmad Fuad and Basri, Mahiran and Basri, Hamidon (2018) Development of nanoemulsion for efficient brain parental delivery of cefuroxime: designs,characterizations,and pharmacokinetics. International Journal of Nanomedicine, 2018 (13). 2571 - 2584. ISSN 1176-9114; ESSN: 1178-2013

Abstract

Background and aim: Drugs that are effective against diseases in the central nervous system and reach the brain via blood must pass through the blood–brain barrier (BBB), a unique interface that protects against potential harmful molecules. This presents a major challenge in neuro-drug delivery. This study attempts to fabricate the cefuroxime-loaded nanoemulsion (CLN) to increase drug penetration into the brain when parenterally administered. Methods: The nanoemulsions were formulated using a high-pressure homogenization technique and were characterized for their physicochemical properties. Results: The characterizations revealed a particle size of 100.32±0.75 nm, polydispersity index of 0.18±0.01, zeta potential of -46.9±1.39 mV, viscosity of 1.24±0.34 cps, and osmolality of 285.33±0.58 mOsm/kg, indicating that the nanoemulsion has compatibility for parenteral application. CLN was physicochemically stable within 6 months of storage at 4°C, and the transmission electron microscopy revealed that the CLN droplets were almost spherical in shape. The in vitro release of CLN profile followed a sustained release pattern. The pharmacokinetic profile of CLN showed a significantly higher Cmax, area under the curve (AUC)0–t, prolonged half-life, and lower total plasma clearance, indicating that the systemic concentration of cefuroxime was higher in CLN-treated rats as compared to cefuroxime-free treated rats. A similar profile was obtained for the biodistribution of cefuroxime in the brain, in which CLN showed a significantly higher Cmax, AUC0–t, prolonged half-life, and lower clearance as compared to free cefuroxime solution. Conclusion: Overall, CLN showed excellent physicochemical properties, fulfilled the requirements for parenteral administration, and presented improved in vivo pharmacokinetic profile, which reflected its practical approach to enhance cefuroxime delivery to the brain.


Download File

[img] Text
development-of-nanosystem-efficient-utilizing-emulsion-for-b_042618.pdf
Restricted to Repository staff only

Download (1MB)

Additional Metadata

Item Type: Article
Divisions: Faculty of Agriculture
Faculty of Medicine and Health Science
Faculty of Science
Halal Products Research Institute
DOI Number: https://doi.org/10.2147/IJN.S151788
Publisher: Dove Medical Press
Keywords: Parenteral nanoemulsion; Cefuroxime; Drug delivery; Pharmacokinetics; Blood–brain barrier
Depositing User: Nurul Ainie Mokhtar
Date Deposited: 27 Apr 2020 06:23
Last Modified: 27 Apr 2020 06:23
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.2147/IJN.S151788
URI: http://psasir.upm.edu.my/id/eprint/72266
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item